Aliases & Classifications for Congestive Heart Failure

MalaCards integrated aliases for Congestive Heart Failure:

Name: Congestive Heart Failure 38 12 29 14 69
Heart Failure 42 69
Cardiac Failure Congestive 12
Congestive Heart Disease 12
Heart Failure Congestive 52
Weak Heart 12
Chf 12

Classifications:



Summaries for Congestive Heart Failure

Disease Ontology : 12 A heart disease that is characterized by any structural or functional cardiac disorder that impairs the ability of the heart to fill with or pump a sufficient amount of blood throughout the body.

MalaCards based summary : Congestive Heart Failure, also known as heart failure, is related to adult respiratory distress syndrome and peripheral artery disease, and has symptoms including angina pectoris, chest pain and edema. An important gene associated with Congestive Heart Failure is NPPA (Natriuretic Peptide A), and among its related pathways/superpathways are Cardiac conduction and Vascular smooth muscle contraction. The drugs Alogliptin and Linagliptin have been mentioned in the context of this disorder. Affiliated tissues include Adipose and Lateral Plate Mesoderm, and related phenotypes are cardiovascular system and homeostasis/metabolism

Related Diseases for Congestive Heart Failure

Diseases related to Congestive Heart Failure via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 342)
id Related Disease Score Top Affiliating Genes
1 adult respiratory distress syndrome 30.5 ACE ADRB1 EDN1 NPPA NPPB
2 peripheral artery disease 30.2 ACE AGTR1 EDN1 NPPB REN
3 poems syndrome 30.1 EPO MME
4 pericarditis 30.1 ACE EDN1 KNG1 REN
5 myocardial infarction 28.2 ACE ADM ADRB1 ADRB2 AGTR1 EDN1
6 polycystic kidney disease 4, with or without hepatic disease 11.4
7 rheumatic heart disease 11.4
8 mental retardation, x-linked, syndromic 32 11.2
9 pulmonary edema 11.2
10 peripartum cardiomyopathy 11.1
11 congenital hepatic fibrosis 11.1
12 hypothyroidism due to iodide transport defect 11.0 ACE REN
13 pleural disease 10.9
14 ventricular septal defect 3 10.9
15 ventricular septal defect 2 10.9
16 ventricular septal defect 1 10.9
17 chronic granulomatous disease 10.9 NPPB REN
18 crimean-congo hemorrhagic fever 10.9
19 uterine inflammatory disease 10.9 EDN1 REN
20 primary hyperoxaluria 10.9 ACE REN
21 atrial septal defect 7, with or without av conduction defects 10.9 ACE NPPA REN
22 hypodontia of incisors and premolars 10.9 ACE NPPA REN
23 synovial chondromatosis 10.9 ACE NPPA NPPB
24 suppurative otitis media 10.9 ACE NPPA NPPB
25 myxozoa 10.9 MYH6 MYH7
26 mody, type ii 10.9 ACE REN
27 urinary bladder posterior wall cancer 10.8 NPPA NPPB REN
28 silver-russell syndrome due to 11p15 microduplication 10.8 EDN1 NPPA REN
29 listeriosis 10.8 ACE REN
30 adams-oliver syndrome 5 10.8 ACE NPPB REN
31 cardiomyopathy, dilated, 1a 10.8
32 atrial fibrillation, familial, 10 10.8
33 atrial fibrillation, familial, 7 10.8
34 cardiomyopathy, dilated, 3b 10.8
35 arterial calcification of infancy 10.8
36 aneurysm of sinus of valsalva 10.8
37 atransferrinemia 10.8
38 cardiomyopathy, dilated, 1x 10.8
39 cardiomyopathy, dilated, 1o 10.8
40 cardiomyopathy, dilated, 1v 10.8
41 cardiomyopathy, dilated, 1gg 10.8
42 cardiomyopathy, dilated, 1kk 10.8
43 atrial fibrillation, familial, 12 10.8
44 malouf syndrome 10.8
45 cardiomyopathy, dilated, 1d 10.8
46 atrial fibrillation 15 10.8
47 cardiomyopathy, dilated, 1w 10.8
48 cardiomyopathy, dilated, 1ee 10.8
49 dyserythropoietic anemia, congenital, type ia 10.8
50 carcinoid syndrome 10.8

Graphical network of the top 20 diseases related to Congestive Heart Failure:



Diseases related to Congestive Heart Failure

Symptoms & Phenotypes for Congestive Heart Failure

UMLS symptoms related to Congestive Heart Failure:


angina pectoris, chest pain, edema, tremor, equilibration disorder, syncope

MGI Mouse Phenotypes related to Congestive Heart Failure:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.17 ACE ADM ADRB1 ADRB2 AGTR1 EDN1
2 homeostasis/metabolism MP:0005376 10.13 ACE ADM ADRB1 ADRB2 AGTR1 EDN1
3 mortality/aging MP:0010768 9.97 MYH6 NPPC NPR1 NR3C2 REN VCL
4 muscle MP:0005369 9.73 MYH6 MYH7 NPPA NPR1 NR3C2 REN
5 renal/urinary system MP:0005367 9.17 AGTR1 EDN1 NPPA NR3C2 REN ACE

Drugs & Therapeutics for Congestive Heart Failure

Drugs for Congestive Heart Failure (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 980)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Alogliptin Approved Phase 4 850649-61-5 11450633
2
Linagliptin Approved Phase 4,Phase 3 668270-12-0 10096344
3
Saxagliptin Approved Phase 4,Phase 3 361442-04-8 11243969
4
Vildagliptin Approved, Investigational Phase 4 274901-16-5 6918537
5
Furosemide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 54-31-9 3440
6
Hydrochlorothiazide Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 58-93-5 3639
7
Metolazone Approved Phase 4,Phase 2,Phase 1 17560-51-9 4170
8
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 51-61-6, 62-31-7 681
9
Dobutamine Approved Phase 4,Phase 2,Phase 3,Phase 1 34368-04-2 36811
10
Digoxin Approved Phase 4,Phase 2,Phase 3,Phase 1 20830-75-5 30322 2724385
11
Spironolactone Approved Phase 4,Phase 2,Phase 3,Phase 1,Early Phase 1 1952-01-7, 52-01-7 5833
12
Methyltestosterone Approved Phase 4,Phase 2 58-18-4 6010
13
Testosterone Approved, Investigational Phase 4,Phase 2 58-22-0 6013
14
Carvedilol Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 72956-09-3 2585
15
Verapamil Approved Phase 4,Phase 3 52-53-9 2520
16
Amiodarone Approved, Investigational Phase 4,Phase 3,Phase 2 1951-25-3 2157
17
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
18
Menthol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 2216-51-5 16666
19
Budesonide Approved Phase 4 51333-22-3 63006 5281004
20
Ipratropium Approved Phase 4,Phase 3 22254-24-6, 60205-81-4 43232
21
Terbutaline Approved Phase 4 23031-25-6 5403
22
Enalapril Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 75847-73-3 5362032 40466924
23
Enalaprilat Approved Phase 4,Phase 3,Phase 2,Phase 1 76420-72-9 6917719
24
Metoprolol Approved, Investigational Phase 4,Phase 3,Phase 2 37350-58-6, 51384-51-1 4171
25
Enfuvirtide Approved, Investigational Phase 4 159519-65-0 16130199
26
Bisoprolol Approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 66722-44-9 2405
27
Candesartan Approved Phase 4,Phase 3,Phase 2,Phase 1 139481-59-7 2541
28
Captopril Approved Phase 4,Phase 3,Phase 1,Early Phase 1 62571-86-2 44093
29
Eplerenone Approved Phase 4,Phase 2,Phase 3,Phase 1 107724-20-9 150310 443872
30
Lisinopril Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 83915-83-7, 76547-98-3 5362119
31
Nebivolol Approved, Investigational Phase 4,Phase 2,Phase 3 152520-56-4, 99200-09-6, 118457-14-0 71301
32
Ramipril Approved Phase 4,Phase 3,Phase 2 87333-19-5 5362129
33
Valsartan Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 137862-53-4 60846
34
Dalteparin Approved Phase 4,Phase 3,Phase 2 9005-49-6
35
Heparin Approved, Investigational Phase 4,Phase 3,Phase 2 9005-49-6 772 46507594
36
Bivalirudin Approved, Investigational Phase 4,Phase 3 128270-60-0 16129704
37
Tenecteplase Approved Phase 4,Phase 3,Phase 2 191588-94-0
38
Tirofiban Approved Phase 4 144494-65-5 60947
39
Acarbose Approved, Investigational Phase 4,Phase 3 56180-94-0 441184
40
Pravastatin Approved Phase 4,Phase 3 81093-37-0 54687
41
Pioglitazone Approved, Investigational Phase 4,Phase 3,Phase 2 111025-46-8 4829
42
Amlodipine Approved Phase 4,Phase 3,Phase 2,Early Phase 1 88150-42-9 2162
43
Everolimus Approved Phase 4,Phase 3,Phase 1,Phase 2 159351-69-6 6442177
44
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
45
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 53123-88-9 5284616 6436030 46835353
46
Cyclophosphamide Approved, Investigational Phase 4,Phase 2,Phase 3,Phase 1 50-18-0, 6055-19-2 2907
47
Doxorubicin Approved, Investigational Phase 4,Phase 3,Phase 2 23214-92-8 31703
48
Epirubicin Approved Phase 4,Phase 3,Phase 2 56420-45-2 41867
49
Fluorouracil Approved Phase 4,Phase 3,Phase 2,Phase 1 51-21-8 3385
50
Amiloride Approved Phase 4,Phase 2,Phase 3,Phase 1 2016-88-8, 2609-46-3 16231

Interventional clinical trials:

(show top 50) (show all 4987)

id Name Status NCT ID Phase Drugs
1 DPP-4 Inhibitor and Serum BNP Level of Diabetic Patients With Congestive Heart Failure Unknown status NCT02312427 Phase 4 Suspending DPP-4 inhibitor, in outpatient service;Starting DPP-4 inhibitor after treatment of heart failure
2 Evaluation of Sildenafil for the Treatment of Moderate Congestive Heart Failure Unknown status NCT00793338 Phase 4 Sildenafil
3 Add-on Aliskiren Treatment in Patients With Chronic Congestive Heart Failure Unknown status NCT01040494 Phase 4 Aliskiren;Placebo
4 A Comparison of Hydrochlorothiazide and Metolazone in Combination With Furosemide in Congestive Heart Failure Patients Unknown status NCT00690521 Phase 4 metolazone or hydrochlorothiazide
5 THalidomide on Left ventricUlar Morphology aND Function in congEstive heaRt Failure Unknown status NCT01640639 Phase 4 Thalidomide;Placebo
6 Long-Term Intermittent Administration of Levosimendan in Patients With Advanced Heart Failure Unknown status NCT00988806 Phase 4 Levosimendan;Placebo
7 PREVENT-HF: Prevention of Heart Failure Events With Impedance Cardiography Testing Unknown status NCT00409916 Phase 4
8 A Strategy of Home Telehealth for Management of Congestive Heart Failure(STARTEL) Unknown status NCT00247000 Phase 4
9 Dopamine in Acute Decompensated Heart Failure (DAD-HF) Trial Unknown status NCT00937092 Phase 4 Furosemide;low-dose dopamine + low-dose furosemide
10 Outcome and Safety of Intermittent Dobutamine Infusion at a Day-Care Center in Advanced Heart Failure Patients Unknown status NCT01930734 Phase 4 Dobutamine;Normal Saline
11 Improvement of Patients With Chronic Heart Failure Using NT-proBNP Unknown status NCT00601679 Phase 4
12 Digoxin Versus Ivabradine in Heart Failure With Reduced Ejection Fraction Unknown status NCT02046044 Phase 4 Digoxin;Ivabradine
13 Medtronic South Asian Systolic Heart Failure Registry Unknown status NCT01434615 Phase 4
14 Quadripolar Leads for the Management of Heart Failure Patients in the Middle East Unknown status NCT02195843 Phase 4
15 Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure Unknown status NCT00527059 Phase 4 Levosimendan in addition to standard therapy;spironolactone, beta-blockers,ecc
16 Benefit of the Treatment With Testosterone in Chronic Heart Failure Testosterone Deficiency Subjects Unknown status NCT01813201 Phase 4 Testosterone undecanoate;Saline isotonic solution
17 Investigator Initiated Randomized Open-label Comparative Study of Britomar (Prolonged Release Torasemide) and Diuver (Torasemide) to Assess Effects on Natriuresis and Central Hemodynamics. Unknown status NCT02087332 Phase 4 Prolonged release Torasemide (Britomar);Torasemide (Diuver)
18 Carvedilol Versus Verapamil in Chronic Heart Failure Secondary to Non-Ischemic Cardiomyopathy Unknown status NCT00348530 Phase 4 Verapamil
19 Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism Unknown status NCT02316743 Phase 4 Levothyroxine supplementation
20 Effects of Atrial Rate-adaptive Pacing on Exercise Capacity in Patients With Chronic Heart Failure Complicated by Chronotropic Incompetence Unknown status NCT01016431 Phase 4
21 Significance of Regional Ventriculo-arterial Coupling in Patients With Chronic Heart Failure Unknown status NCT01156207 Phase 4 Aliskiren
22 Therapy With Verapamil or Carvedilol in Chronic Heart Failure Unknown status NCT00374465 Phase 4 Verapamil;Carvedilol
23 A Study to Evaluate the Efficacy and Safety of Shenfu Zhusheye in Patients With Acute Heart Failure Unknown status NCT02135835 Phase 4 Shenfu Zhusheye;5% glucose injection
24 Shensong Yangxin Capsule in the Treatment of Heart Failure Complicated With Ventricular Premature Beat Unknown status NCT01612260 Phase 4 Shensong Yangxin capsule;placebo Capsule
25 N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure Unknown status NCT00692718 Phase 4 Epadel, Eicosapentaenoic acid
26 Danish ICD Study in Patients With Dilated Cardiomyopathy Unknown status NCT00542945 Phase 4
27 CARE-HF LTFU: CArdiac REsynchronization in Heart Failure Long-Term Follow-up Unknown status NCT00318357 Phase 4
28 Resynchronization in Paced Heart Failure Patients With Implantable Cardioverter Defibrillator (ICD) Indication Unknown status NCT01415024 Phase 4
29 Treatment of Cheyne Stocks Respiration With Adaptive Servo Ventilation and Bilevel Ventilators in Patients With Chronic Heart Failure Unknown status NCT00725595 Phase 4
30 Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot Study Unknown status NCT01850277 Phase 4 Amiodarone;Pharmacotherapy to slow and control ventricular rate
31 LTOT in COPD Patients With Moderate Chronic Hypoxemia and Chronic Heart Failure Unknown status NCT00668408 Phase 4
32 St. Vincent's Screening To Prevent Heart Failure Study Unknown status NCT00921960 Phase 4
33 Anti-Hypertensive Agent (ACEi) and Heart Function Improvement in Association With Rho Kinase Activity Changes in Human Unknown status NCT01069042 Phase 4 Enalapril
34 The Angiotensin Converting Enzyme (ACE) Inhibitor SwitchBack Study Unknown status NCT01162980 Phase 4
35 Ability of Metoprolol to Alter the Exercise Induced Elevation of Catecholamines Unknown status NCT00885651 Phase 4 Metoprolole (Selo-Zok ®);Placebo
36 Surgical Treatment of Ischemic Mitral Regurgitation Unknown status NCT01368575 Phase 4
37 Effects of Atorvastatin Treatment on Left Ventricular Diastolic Function in Peritoneal Dialysis Patients Unknown status NCT01503671 Phase 4 Atorvastatin
38 Latin America Cardiac Resynchronization Therapy Study Unknown status NCT01238874 Phase 4
39 Ivabradine in Patients With an Unsatisfactory Percentage of Cardiac Resynchronization Therapy Unknown status NCT02166060 Phase 4 Ivabradine
40 Study Tests Whether a Standardized LVR Performed With the Blue Egg Device Improves Cardiopulmonary Exercise Capacity Unknown status NCT00326690 Phase 4
41 Mode Evaluation in Sick Sinus Syndrome Trial (MODEST) Unknown status NCT00161551 Phase 4
42 Ventricular Pacing Site Selection (V-PASS) Unknown status NCT00292383 Phase 4
43 Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients Unknown status NCT02200822 Phase 4 beta blockers;RAAS blockers
44 Revascularization in Heart Failure Trial – REHEAT 2 Unknown status NCT00388245 Phase 4
45 A Morbidity-Mortality and Remodeling Study With Valsartan Unknown status NCT00133328 Phase 4 valsartan
46 Erythropoietin Treatment in Patients With Systolic Left Ventricular Dysfunction, Mild Anemia and Normal Renal Function Unknown status NCT00418119 Phase 4 erythropoietin
47 Changes of Left Ventricular Mass and Cardiac Function in Patients With Active Acromegaly During Treatment With the Growth Hormone Receptor Antagonist Pegvisomant Unknown status NCT00552851 Phase 4 pegvisomant
48 Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism Unknown status NCT02132689 Phase 4 Actilyse (Thrombolytic therapy);Heparine (Standard anticoagulation therapy)
49 Effect of Conditioning on Myocardial Damage in STEMI Unknown status NCT02158468 Phase 4
50 Right Ventricular Septal Pacing for the Prevention of Left Ventricular Dysfunction in Patients With Atrio-Ventricular Block Unknown status NCT00709774 Phase 4

Search NIH Clinical Center for Congestive Heart Failure

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Congestive Heart Failure cell therapies at LifeMap Discovery.
Stem-cell-based therapeutic approaches for Congestive Heart Failure:
ACP-01, autologous angiogenic precursor cells for cardiac diseases
Adipose-derived stem cells for treatment of congestive heart failure
BMAC
Bone marrow-derived adult mononuclear cells for heart diseases
Cardiac progenitor cells for single-ventricle anomalies
Cardiosphere-derived autologous stem cells for reverse ventricular dysfunction
C-Cure
CD133+ bone marrow-derived stem cells in conjuction with coronary artery bypass grafting
CD34+ stem cells for treatment of congestive heart failure
Enriched bone marrow-derived progenitor cells for heart diseases
ERCs, endometrial regenerative cells for congestive heart failure
Human cardiac-derived stem cell for the treatment of congestive heart failure
itMSC, bone marrow-derived mesenchymal stem cells for cardiovascular diseases
Mesenchymal precursor cells for cardiovascular diseases
MyoCell
Peripheral or bone marrow-derived stem cells for chronic heart failure
Embryonic/Adult Cultured Cells Related to Congestive Heart Failure:
Angiogenic cell precursors
Adipose-derived mesenchymal stem cells (family)
Bone Marrow Aspirate Concentrated Nucleated Cells (BMAC) PMIDs: 15995108 23788089 18351022
Bone marrow-derived mononuclear cells PMIDs: 22137069 19699857 20445812 20524773
Cardiac stem cells PMIDs: 18754813 17502484 14530411
Cardiac progenitor cells PMIDs: 18754813 17502484 14530411
Cardiosphere-derived cells PMIDs: 22336189
Cardiomyocyte-like cells PMIDs: 23583247 18835562
Bone marrow-derived CD133+ cells PMIDs: 17320570
Bone marrow-derived hematopoietic stem cells (family) PMIDs: 22163120
Bone marrow-derived progenitor cells PMIDs: 23362308 22936827 18794392 16990384 16990385 22651868
Endometrial regenerative cells PMIDs: 18005405 23510656 20398245 19232091
Human cardiac stem cells PMIDs: 17502484 19038683 17150190
Mesenchymal Precursor Cells (STRO-3 selected) PMIDs: 20850099 21155976
Skeletal myoblasts (MyoCell PMIDs: 19051139 15615560 16446778
Bone marrow-derived mononuclear cells PMIDs: 20668107 21596713 19761394 22834565

Cochrane evidence based reviews: heart failure

Genetic Tests for Congestive Heart Failure

Genetic tests related to Congestive Heart Failure:

id Genetic test Affiliating Genes
1 Congestive Heart Failure 29

Anatomical Context for Congestive Heart Failure

MalaCards organs/tissues related to Congestive Heart Failure:

39
Heart, Kidney, Lung, Breast, Testes, Bone, Endothelial
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Congestive Heart Failure:
id Tissue Anatomical CompartmentCell Relevance
1 Adipose Subcutaneous White Adipose Mesenchymal Stem Cells Potential therapeutic candidate
2 Lateral Plate Mesoderm Splanchnic Mesoderm Pericytes Potential therapeutic candidate
3 Adipose Subcutaneous White Adipose Stromal Cells Potential therapeutic candidate

Publications for Congestive Heart Failure

Articles related to Congestive Heart Failure:

(show top 50) (show all 1386)
id Title Authors Year
1
Chilaiditi syndrome mimicking congestive heart failure. ( 28710199 )
2017
2
Histopathological Changes in the Kidney following Congestive Heart Failure by Volume Overload in Rats. ( 28831296 )
2017
3
Veterans' Voice Through the Lens of Their Medical Records: What It Reveals About Congestive Heart Failure Readmissions. ( 27902575 )
2017
4
High-Intensity Training Improves Global and Segmental Strains in Severe Congestive Heart Failure. ( 28069473 )
2017
5
Risk of stroke in congestive heart failure with and without atrial fibrillation. ( 28826798 )
2017
6
The NF-kB regulates the SHP-1 expression in monocytes in congestive heart failure. ( 27814644 )
2017
7
Prognostic Value of Different Allelic Polymorphism of Aldosterone Synthase Receptor in a Congestive Heart Failure European Continental Ancestry Population. ( 28625318 )
2017
8
Frequency and number of B-lines using a regionally based lung ultrasound examination in cats with radiographically normal lungs compared to cats with left-sided congestive heart failure. ( 28763158 )
2017
9
Congestive Heart Failure with Preserved Ejection Fraction in a Patient with Light Chain (AL) Amyloidosis and Multiple Myeloma. ( 28701686 )
2017
10
Use of Biomarkers to Predict Readmission for Congestive Heart Failure. ( 27939586 )
2017
11
Chewable tablets for congestive heart failure in dogs. ( 28883117 )
2017
12
Use of Wavelet Transform to Detect Compensated and Decompensated Stages in the Congestive Heart Failure Patient. ( 28930184 )
2017
13
The evaluation of I^-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study. ( 28894360 )
2017
14
Congestive heart failure: More common as well as an important cardiovascular outcome - reply. ( 28069608 )
2017
15
Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis. ( 28898297 )
2017
16
Unusual cardiac involvement in granulomatosis with polyangiitis manifesting as acute congestive heart failure. ( 28766511 )
2017
17
Congestive Heart Failure During Osimertinib Treatment for Epidermal Growth Factor Receptor (EGFR)-mutant Non-small Cell Lung Cancer (NSCLC). ( 28781309 )
2017
18
Gender-adjusted and age-adjusted economic inpatient burden of congestive heart failure: cost and disability-adjusted life-year analysis. ( 28772046 )
2017
19
Association Between C1q/TNF-Related Protein-1 Levels in Human Plasma and Epicardial Adipose Tissues and Congestive Heart Failure. ( 28810263 )
2017
20
Poor acute outcome in congestive heart failure is associated with increases in the plasma static oxidation-reduction potentials (sORP) in men but not in women. ( 28845739 )
2017
21
Clinical Outcomes of Metformin Use in Populations With Chronic Kidney Disease, Congestive Heart Failure, or Chronic Liver Disease: A Systematic Review. ( 28055049 )
2017
22
Central Sleep Apnea in Patients with Congestive Heart Failure. ( 28477776 )
2017
23
Pathological alterations in liver injury following congestive heart failure induced by volume overload in rats. ( 28934226 )
2017
24
A Case of Fulminant Hepatic Failure Secondary to Congestive Heart Failure Without Evidence of Acute Cardiac Decompensation. ( 28813731 )
2017
25
In-hospital and long-term outcomes of congestive heart failure: Predictive value of B-type and amino-terminal pro-B-type natriuretic peptides and their ratio. ( 28810640 )
2017
26
Processes and Outcomes of Congestive Heart Failure Care by Different Types of Primary Care Models. ( 28870732 )
2017
27
Investigation of the link between fluid shift and airway collapsibility as a mechanism for obstructive sleep apnea in congestive heart failure. ( 28057850 )
2017
28
Serum C-Reactive Protein and Congestive Heart Failure as Significant Predictors of Herpes Zoster Vaccine Response in Elderly Nursing Home Residents. ( 28838148 )
2017
29
Kyoto Congestive Heart Failure (KCHF) study: rationale and design. ( 28772047 )
2017
30
Genome-Wide Association Study for Anthracycline-Induced Congestive Heart Failure. ( 27993963 )
2017
31
Epidemiological profile and obstetric outcomes of patients with peripartum congestive heart failure in Taiwan: a retrospective nationwide study. ( 28899350 )
2017
32
Risk factors for 30-day readmission in patients with congestive heart failure. ( 28801110 )
2017
33
Response by Di Biase et al to Letter Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". ( 27601565 )
2016
34
Trapped lung secondary to cardiomegaly in a 78 year-old male with congestive heart failure. ( 27054087 )
2016
35
Trends in hospitalization for congestive heart failure, 1996-2009. ( 27862089 )
2016
36
The Performance of Short-Term Heart Rate Variability in the Detection of Congestive Heart Failure. ( 27891509 )
2016
37
Can Bedside Ultrasound Inferior Vena Cava Measurements Accurately Diagnose Congestive Heart Failure in the Emergency Department? A Clin-IQ. ( 27857946 )
2016
38
Increased serum C-reactive protein concentrations in dogs with congestive heart failure due to myxomatous mitral valve disease. ( 26831162 )
2016
39
Letter from Turco Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". ( 27601560 )
2016
40
Evaluation of the efficacy of a nurse practitioner-led home-based congestive heart failure clinical pathway. ( 27064361 )
2016
41
Letter from Willey and Biviano Regarding Article, "Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial". ( 27601561 )
2016
42
Common variants in IL-17A/IL-17RA axis contribute to predisposition to and progression of congestive heart failure. ( 27399111 )
2016
43
Potential new drug treatments for congestive heart failure. ( 27104862 )
2016
44
B-type Natriuretic Peptide Assay in Differentiating Congestive Heart Failure from Lung Disease in Patients Presenting with Dyspnea. ( 27612893 )
2016
45
Congestive heart failure detection using random forest classifier. ( 27208521 )
2016
46
A case report of primary cardiac myxofibrosarcoma presenting with severe congestive heart failure. ( 27387491 )
2016
47
Core Measures for Congestive Heart Failure in a Tertiary Care Setting in Pakistan. ( 27630801 )
2016
48
Weight Management Belief is the Leading Influential Factor of Weight Monitoring Compliance in Congestive Heart Failure Patients. ( 27899858 )
2016
49
Efficacy of pimobendan on survival and reoccurrence of pulmonary edema in canine congestive heart failure. ( 27644192 )
2016
50
Evolution of a 90-Day Model of Care for Bundled Episodic Payments for Congestive Heart Failure in Home Care. ( 27158856 )
2016

Variations for Congestive Heart Failure

ClinVar genetic disease variations for Congestive Heart Failure:

6
id Gene Variation Type Significance SNP ID Assembly Location
1 PSEN1 NM_000021.3(PSEN1): c.998A> G (p.Asp333Gly) single nucleotide variant Pathogenic/Likely pathogenic rs121917809 GRCh37 Chromosome 14, 73678519: 73678519

Expression for Congestive Heart Failure

Search GEO for disease gene expression data for Congestive Heart Failure.

Pathways for Congestive Heart Failure

GO Terms for Congestive Heart Failure

Cellular components related to Congestive Heart Failure according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular region GO:0005576 9.7 ACE ADM EDN1 EPO KNG1 NPPA
2 extracellular space GO:0005615 9.32 ACE ADM EDN1 EPO KNG1 NPPA
3 myosin filament GO:0032982 9.16 MYH6 MYH7

Biological processes related to Congestive Heart Failure according to GeneCards Suite gene sharing:

(show all 39)
id Name GO ID Score Top Affiliating Genes
1 cell surface receptor signaling pathway GO:0007166 9.97 ADRB2 EDN1 NPPB NPR1
2 response to drug GO:0042493 9.91 EDN1 NPPC REN UTS2
3 kidney development GO:0001822 9.88 ACE AGTR1 MME REN
4 muscle contraction GO:0006936 9.87 MYH6 MYH7 UTS2 VCL
5 response to organic substance GO:0010033 9.85 ADM AMPD1 REN
6 positive regulation of cytosolic calcium ion concentration GO:0007204 9.85 ADM AGTR1 EDN1 KNG1 UTS2
7 response to lipopolysaccharide GO:0032496 9.84 ADM EDN1 EPO REN
8 regulation of cardiac conduction GO:1903779 9.8 NPPA NPPC NPR1
9 response to cold GO:0009409 9.79 ADM ADRB1 ADRB2
10 response to testosterone GO:0033574 9.77 EDN1 EPO UTS2
11 regulation of vasoconstriction GO:0019229 9.73 ACE AGTR1 EDN1
12 response to hypoxia GO:0001666 9.73 ADM EDN1 EPO NPPA NPPC UTS2
13 regulation of the force of heart contraction GO:0002026 9.72 ADM MYH6 MYH7
14 cGMP biosynthetic process GO:0006182 9.71 NPPA NPPB NPPC NPR1
15 beta-amyloid metabolic process GO:0050435 9.7 ACE MME REN
16 positive regulation of renal sodium excretion GO:0035815 9.69 EDN1 NPPB NPR1
17 response to muscle stretch GO:0035994 9.68 EDN1 NPPA
18 cardiac muscle hypertrophy in response to stress GO:0014898 9.67 MYH7 NPPA
19 positive regulation of urine volume GO:0035810 9.67 EDN1 NPPB NPR1
20 positive regulation of heart rate GO:0010460 9.67 ADM EDN1 NPPA UTS2
21 negative regulation of blood coagulation GO:0030195 9.66 EDN1 KNG1
22 negative regulation of multicellular organism growth GO:0040015 9.66 ADRB1 ADRB2
23 response to dexamethasone GO:0071548 9.65 EDN1 EPO
24 positive regulation of cGMP biosynthetic process GO:0030828 9.65 NPPC NPR1
25 adult heart development GO:0007512 9.65 MYH6 MYH7
26 angiotensin maturation GO:0002003 9.65 ACE MME REN
27 regulation of vascular permeability GO:0043114 9.64 NPPB NPR1
28 diet induced thermogenesis GO:0002024 9.64 ADRB1 ADRB2
29 regulation of blood vessel size GO:0050880 9.63 EDN1 KNG1 NPPA NPPB NPPC NPR1
30 regulation of systemic arterial blood pressure by renin-angiotensin GO:0003081 9.62 ACE AGTR1
31 receptor guanylyl cyclase signaling pathway GO:0007168 9.62 NPPA NPPB NPPC NPR1
32 renin-angiotensin regulation of aldosterone production GO:0002018 9.61 AGTR1 REN
33 body fluid secretion GO:0007589 9.61 EDN1 NPPB NPR1
34 vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure GO:0002025 9.59 ADRB1 ADRB2
35 heat generation GO:0031649 9.58 ADRB1 ADRB2
36 cell growth involved in cardiac muscle cell development GO:0061049 9.37 NPPA
37 negative regulation of systemic arterial blood pressure GO:0003085 9.33 NPPA
38 regulation of blood vessel diameter GO:0097746 9.26 ACE AGTR1 NPPB NPR1
39 regulation of blood pressure GO:0008217 9.23 ACE EDN1 MYH6 NPPA NPPB NPR1

Molecular functions related to Congestive Heart Failure according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 endopeptidase activity GO:0004175 9.63 ACE MME REN
2 receptor binding GO:0005102 9.56